These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28809167)

  • 1. Investigation of β-lactam antibacterial drugs, β-lactamases, and penicillin-binding proteins with fluorescence polarization and anisotropy: a review.
    Shapiro AB
    Methods Appl Fluoresc; 2016 Apr; 4(2):024002. PubMed ID: 28809167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A boronic-acid-based probe for fluorescence polarization assays with penicillin binding proteins and β-lactamases.
    Inglis SR; Strieker M; Rydzik AM; Dessen A; Schofield CJ
    Anal Biochem; 2012 Jan; 420(1):41-7. PubMed ID: 21925482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Mutations in the
    Ranjitkar S; Reck F; Ke X; Zhu Q; McEnroe G; Lopez SL; Dean CR
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.
    Kumar KM; Anbarasu A; Ramaiah S
    Mol Biosyst; 2014 Apr; 10(4):891-900. PubMed ID: 24503740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence anisotropy-based measurement of Pseudomonas aeruginosa penicillin-binding protein 2 transpeptidase inhibitor acylation rate constants.
    Shapiro AB; Gao N; Gu RF; Thresher J
    Anal Biochem; 2014 Oct; 463():15-22. PubMed ID: 24945954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Carboxytetramethylrhodamine-Ampicillin Fluorescence Anisotropy-Based Assay of Escherichia coli Penicillin-Binding Protein 2 Transpeptidase Inhibition.
    Shapiro AB; Comita-Prevoir J; Sylvester M
    ACS Infect Dis; 2019 Jun; 5(6):863-872. PubMed ID: 30848883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin Binding Proteins and β-Lactamases of Mycobacterium tuberculosis: Reexamination of the Historical Paradigm.
    Kumar G; Galanis C; Batchelder HR; Townsend CA; Lamichhane G
    mSphere; 2022 Feb; 7(1):e0003922. PubMed ID: 35196121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and mechanistic aspects of evolution of beta-lactamases and penicillin-binding proteins.
    Massova I; Mobashery S
    Curr Pharm Des; 1999 Nov; 5(11):929-37. PubMed ID: 10539997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic-membrane anchoring of a class A beta-lactamase and its capacity in manifesting antibiotic resistance.
    Suvorov M; Vakulenko SB; Mobashery S
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2937-42. PubMed ID: 17502412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial resistance against beta-lactam antibiotics].
    Andersen BM
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM; Wood MJ
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure.
    Ropy A; Cabot G; Sánchez-Diener I; Aguilera C; Moya B; Ayala JA; Oliver A
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3925-34. PubMed ID: 25896695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin-binding proteins in Actinobacteria.
    Ogawara H
    J Antibiot (Tokyo); 2015 Apr; 68(4):223-45. PubMed ID: 25351947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.
    Essack SY
    Pharm Res; 2001 Oct; 18(10):1391-9. PubMed ID: 11697463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.